Q2 Earnings Forecast for VRDN Issued By B. Riley
Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) – Analysts at B. Riley issued their Q2 2025 earnings per share estimates for shares of Viridian Therapeutics in a report issued on Monday, March 3rd. B. Riley analyst K. Patel expects that the company will post earnings of ($1.14) per share for the quarter. The consensus estimate […]
Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) – Analysts at B. Riley issued their Q2 2025 earnings per share estimates for shares of Viridian Therapeutics in a report issued on Monday, March 3rd. B. Riley analyst K. Patel expects that the company will post earnings of ($1.14) per share for the quarter. The consensus estimate […]
